| Abiraterone acetate for metastatic castration-resistant prostate cancer after docetaxel failure: A randomized, double-blind, placebo-controlled phase 3 bridging study | |
| Sun, Yinghao; Zou, Qing; Sun, Zhongquan; Li, Changling; Du, Chuanjun; Chen, Zhiwen; Shan, Yuxi; Huang, Yiran; Jin, Jie; Ye, Zhang Qun | |
| 刊名 | INTERNATIONAL JOURNAL OF UROLOGY
 |
| 2016 | |
| 卷号 | 23期号:5 |
| 关键词 | abiraterone acetate Asian population castration-resistant prostate cancer docetaxel phase 3 |
| ISSN号 | 0919-8172 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4287088 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Sun, Yinghao,Zou, Qing,Sun, Zhongquan,et al. Abiraterone acetate for metastatic castration-resistant prostate cancer after docetaxel failure: A randomized, double-blind, placebo-controlled phase 3 bridging study[J]. INTERNATIONAL JOURNAL OF UROLOGY,2016,23(5). |
| APA | Sun, Yinghao.,Zou, Qing.,Sun, Zhongquan.,Li, Changling.,Du, Chuanjun.,...&Ye, Dingwei.(2016).Abiraterone acetate for metastatic castration-resistant prostate cancer after docetaxel failure: A randomized, double-blind, placebo-controlled phase 3 bridging study.INTERNATIONAL JOURNAL OF UROLOGY,23(5). |
| MLA | Sun, Yinghao,et al."Abiraterone acetate for metastatic castration-resistant prostate cancer after docetaxel failure: A randomized, double-blind, placebo-controlled phase 3 bridging study".INTERNATIONAL JOURNAL OF UROLOGY 23.5(2016). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论